Astromech Raises $20 Million
Astromech, a company specializing in developing AI models that predict biological changes using genomic and evolutionary data, has successfully raised $20 million. The funding round, led by prominent biotech investor Bob Nelsen, also saw participation from Peak 6, NeoGenesis Capital, Builders VC, and CAZ Investments.
Co-founded by Ben Lamm and George Church, Astromech aims to leverage this new capital to further its research capabilities. The company uses its expertise to forecast how living systems might evolve, identifying potential genetic bottlenecks and responses to environmental changes. This approach is likened to weather forecasting, where historical data informs future predictions.
Use of Funds
The newly acquired funding will be directed towards expanding Astromech's research team and increasing the number of species included in its genomic datasets. Additionally, the company plans to scale its comparative genomic infrastructure, enhancing the training of its predictive models.
Location
Astromech is headquartered in Dallas, Texas, United States.
About the Company
Astromech's innovative work in predictive biology extends beyond current biological research methods, moving towards anticipating future biological trajectories. By harnessing approximately 3.8 billion years of evolutionary history, the company seeks to recognize patterns of resilience and adaptation in biological systems.